Brief: Hofseth Biocare Q3 Revenue NOK 54.9 Million
07/11/2025 07:00
Nov 07 (Reuters) - Hofseth Biocare Q3 EBITDA NOK -21.1 million.
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering